• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙调神经磷酸酶(CN)在肾肾小球足细胞中的作用:CN抑制剂通过抑制CN在裂孔隔膜处的重新分布改善蛋白尿。

Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm.

作者信息

Wakamatsu Ayako, Fukusumi Yoshiyasu, Hasegawa Eriko, Tomita Masayuki, Watanabe Toru, Narita Ichiei, Kawachi Hiroshi

机构信息

Department of Cell Biology, Institute of Nephrology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan Division of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

Department of Cell Biology, Institute of Nephrology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.

出版信息

Physiol Rep. 2016 Mar;4(6). doi: 10.14814/phy2.12679.

DOI:10.14814/phy2.12679
PMID:27009276
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4814882/
Abstract

Although calcineurin (CN) is distributed in many cell types and functions in regulating cell functions, the precise roles ofCNremained in each type of the cells are not well understood yet. ACNinhibitor (CNI) has been used for steroid-resistant nephrotic syndrome. ACNIis assumed to ameliorate proteinuria by preventing the overproduction of T-cell cytokines. However, recent reports suggest thatCNIhas a direct effect on podocyte. It is accepted that a slit diaphragm (SD), a unique cell-cell junction of podocytes, is a critical barrier preventing a leak of plasma protein into urine. Therefore, we hypothesized thatCNIhas an effect on theSD In this study, we analyzed the expression ofCNin physiological and in the nephrotic model caused by the antibody against nephrin, a critical component of theSD We observed thatCNis expressed at theSDin normal rat and human kidney sections and has an interaction with nephrin. The staining ofCNat theSDwas reduced in the nephrotic model, whileCNactivity in glomeruli was increased. We also observed that the treatment with tacrolimus, aCNI, in this nephrotic model suppressed the redistribution ofCN, nephrin, and otherSDcomponents and ameliorated proteinuria. These observations suggested that the redistribution and the activation ofCNmay participate in the development of theSDinjury.

摘要

尽管钙调神经磷酸酶(CN)分布于多种细胞类型中并在调节细胞功能方面发挥作用,但CN在每种细胞类型中的确切作用尚未完全明确。一种CN抑制剂(CNI)已被用于治疗激素抵抗型肾病综合征。人们认为CNI通过阻止T细胞细胞因子的过度产生来改善蛋白尿。然而,最近的报道表明CNI对足细胞有直接作用。人们公认,裂孔隔膜(SD)是足细胞独特的细胞间连接,是防止血浆蛋白漏入尿液的关键屏障。因此,我们推测CNI对SD有影响。在本研究中,我们分析了CN在生理状态下以及在由针对SD关键成分nephrin的抗体引起的肾病模型中的表达情况。我们观察到,在正常大鼠和人类肾脏切片中,CN在SD处表达,并且与nephrin相互作用。在肾病模型中,SD处CN的染色减少,而肾小球中CN的活性增加。我们还观察到,在该肾病模型中用CNI他克莫司进行治疗可抑制CN、nephrin和其他SD成分的重新分布,并改善蛋白尿。这些观察结果表明,CN的重新分布和激活可能参与了SD损伤的发生发展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/9a8db2af07af/PHY2-4-e12679-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/af939db9e9bb/PHY2-4-e12679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/709f6bb11702/PHY2-4-e12679-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/ffa16ffdeec0/PHY2-4-e12679-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/84f4d8518b92/PHY2-4-e12679-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/a35e8f2194d0/PHY2-4-e12679-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/179c3b50808c/PHY2-4-e12679-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/9a8db2af07af/PHY2-4-e12679-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/af939db9e9bb/PHY2-4-e12679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/709f6bb11702/PHY2-4-e12679-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/ffa16ffdeec0/PHY2-4-e12679-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/84f4d8518b92/PHY2-4-e12679-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/a35e8f2194d0/PHY2-4-e12679-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/179c3b50808c/PHY2-4-e12679-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a113/4814882/9a8db2af07af/PHY2-4-e12679-g007.jpg

相似文献

1
Role of calcineurin (CN) in kidney glomerular podocyte: CN inhibitor ameliorated proteinuria by inhibiting the redistribution of CN at the slit diaphragm.钙调神经磷酸酶(CN)在肾肾小球足细胞中的作用:CN抑制剂通过抑制CN在裂孔隔膜处的重新分布改善蛋白尿。
Physiol Rep. 2016 Mar;4(6). doi: 10.14814/phy2.12679.
2
Slit diaphragm dysfunction in proteinuric states: identification of novel therapeutic targets for nephrotic syndrome.蛋白尿状态下的裂孔隔膜功能障碍:肾病综合征新治疗靶点的鉴定
Clin Exp Nephrol. 2009 Aug;13(4):275-280. doi: 10.1007/s10157-009-0162-x. Epub 2009 Mar 7.
3
Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys.神经连接蛋白-1 是一种突触前黏附分子,定位于肾脏肾小球足细胞的裂孔隔膜。
Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R340-8. doi: 10.1152/ajpregu.00640.2009. Epub 2010 Nov 3.
4
The calcineurin inhibitor tacrolimus reduces proteinuria in membranous nephropathy accompanied by a decrease in angiopoietin-like-4.钙调神经磷酸酶抑制剂他克莫司可降低膜性肾病患者的蛋白尿,同时血管生成素样蛋白4水平也会下降。
PLoS One. 2014 Aug 28;9(8):e106164. doi: 10.1371/journal.pone.0106164. eCollection 2014.
5
Calcineurin inhibitors ameliorate PAN-induced podocyte injury through the NFAT-Angptl4 pathway.钙调磷酸酶抑制剂通过 NFAT-Angptl4 通路改善 PAN 诱导的足细胞损伤。
J Pathol. 2020 Nov;252(3):227-238. doi: 10.1002/path.5512. Epub 2020 Sep 8.
6
Podocyte protection by darbepoetin: preservation of the cytoskeleton and nephrin expression.达贝泊汀对足细胞的保护作用:细胞骨架的保存及nephrin表达
Kidney Int. 2007 Aug;72(4):455-63. doi: 10.1038/sj.ki.5002311. Epub 2007 Apr 25.
7
Administration of pigment epithelium-derived factor (PEDF) reduces proteinuria by suppressing decreased nephrin and increased VEGF expression in the glomeruli of adriamycin-injected rats.给予色素上皮衍生因子(PEDF)可通过抑制阿霉素注射大鼠肾小球中nephrin表达降低和VEGF表达增加来减少蛋白尿。
Nephrol Dial Transplant. 2009 May;24(5):1397-406. doi: 10.1093/ndt/gfn659. Epub 2008 Nov 28.
8
Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.p38丝裂原活化蛋白激酶激活在实验性肾病综合征足细胞损伤和蛋白尿中的作用
J Am Soc Nephrol. 2005 Sep;16(9):2690-701. doi: 10.1681/ASN.2004121084. Epub 2005 Jun 29.
9
Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria.足细胞在患有严重蛋白尿的肾脏中与肾小球基底膜紧密相连。
J Am Soc Nephrol. 2004 Oct;15(10):2611-8. doi: 10.1097/01.ASN.0000139478.03463.D9.
10
Qi-Dan Fang ameliorates adriamycin-induced nephrotic syndrome rat model by enhancing renal function and inhibiting podocyte injury.芪丹方通过增强肾功能和抑制足细胞损伤改善阿霉素肾病综合征大鼠模型。
J Ethnopharmacol. 2014 Feb 12;151(3):1124-1132. doi: 10.1016/j.jep.2013.12.028. Epub 2014 Jan 3.

引用本文的文献

1
Revisiting nephrin signaling and its specialized effects on the uniquely adaptable podocyte.重新审视nephrin信号传导及其对独特适应性足细胞的特殊作用。
Biochem J. 2025 Jun 2;482(11):763-88. doi: 10.1042/BCJ20230234.
2
The Ca-actin-cytoskeleton axis in podocytes is an important, non-immunologic target of immunosuppressive therapy in proteinuric kidney diseases.足细胞中的钙-肌动蛋白-细胞骨架轴是蛋白尿性肾脏疾病免疫抑制治疗的重要非免疫靶点。
Pediatr Nephrol. 2025 Jan 25. doi: 10.1007/s00467-025-06670-z.
3
Novel mutation patterns in children with steroid-resistant nephrotic syndrome.

本文引用的文献

1
Alteration in the podoplanin-ezrin-cytoskeleton linkage is an important initiation event of the podocyte injury in puromycin aminonucleoside nephropathy, a mimic of minimal change nephrotic syndrome.Podoplanin-ezrin-细胞骨架连接的改变是嘌呤霉素氨基核苷肾病(微小病变肾病综合征的一种模拟模型)中足细胞损伤的重要起始事件。
Cell Tissue Res. 2015 Oct;362(1):201-13. doi: 10.1007/s00441-015-2178-8. Epub 2015 Apr 29.
2
SV2B is essential for the integrity of the glomerular filtration barrier.突触囊泡蛋白2B(SV2B)对于肾小球滤过屏障的完整性至关重要。
Lab Invest. 2015 May;95(5):534-45. doi: 10.1038/labinvest.2015.39. Epub 2015 Mar 2.
3
激素抵抗型肾病综合征患儿的新型突变模式
Clin Kidney J. 2024 Jul 23;17(8):sfae218. doi: 10.1093/ckj/sfae218. eCollection 2024 Aug.
4
Voclosporin: Unique Chemistry, Pharmacology and Toxicity Profile, and Possible Options for Implementation into the Management of Lupus Nephritis.伏考利苷:独特的化学、药理学和毒理学特性,以及在狼疮肾炎治疗中应用的可能选择。
Cells. 2023 Oct 11;12(20):2440. doi: 10.3390/cells12202440.
5
Efficacy and safety of tacrolimus-based treatment for non-rapidly progressive IgA nephropathy.他克莫司治疗非快速进展性IgA肾病的疗效与安全性。
Front Pharmacol. 2023 May 18;14:1189608. doi: 10.3389/fphar.2023.1189608. eCollection 2023.
6
The Clinical and Genetic Features in Chinese Children With Steroid-Resistant or Early-Onset Nephrotic Syndrome: A Multicenter Cohort Study.中国儿童激素抵抗型或早发性肾病综合征的临床及遗传特征:一项多中心队列研究
Front Med (Lausanne). 2022 Jun 9;9:885178. doi: 10.3389/fmed.2022.885178. eCollection 2022.
7
Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy.他克莫司通过下调糖尿病肾病中 TRPC6 保护足细胞免于凋亡。
J Diabetes Res. 2021 May 20;2021:8832114. doi: 10.1155/2021/8832114. eCollection 2021.
8
Morphological analyses of nephrin expression in progressive glomerulonephropathy of common marmosets.普通狨猴进行性肾小球肾炎中nephrin表达的形态学分析。
J Toxicol Pathol. 2021 Jan;34(1):83-88. doi: 10.1293/tox.2020-0056. Epub 2020 Nov 21.
9
Kidney podocyte-associated gene polymorphisms affect tacrolimus concentration in pediatric patients with refractory nephrotic syndrome.肾足细胞相关基因多态性影响难治性肾病综合征患儿的他克莫司血药浓度。
Pharmacogenomics J. 2020 Aug;20(4):543-552. doi: 10.1038/s41397-019-0141-x. Epub 2020 Jan 6.
10
Off-label use of tacrolimus in children with glomerular disease: Effectiveness, safety and pharmacokinetics.他克莫司在儿童肾小球疾病中的超说明书用药:有效性、安全性及药代动力学
Br J Clin Pharmacol. 2020 Feb;86(2):274-284. doi: 10.1111/bcp.14174. Epub 2020 Jan 14.
Non-immunologic actions of calcineurin inhibitors in proteinuric kidney diseases.
钙调神经磷酸酶抑制剂在蛋白尿性肾脏疾病中的非免疫作用。
Front Endocrinol (Lausanne). 2014 Nov 12;5:181. doi: 10.3389/fendo.2014.00181. eCollection 2014.
4
Cyclosporine A protects podocytes via stabilization of cofilin-1 expression in the unphosphorylated state.环孢素A通过稳定非磷酸化状态的丝切蛋白-1的表达来保护足细胞。
Exp Biol Med (Maywood). 2014 Aug;239(8):922-936. doi: 10.1177/1535370214530365. Epub 2014 Apr 15.
5
Calcineurin inhibitors: 40 years later, can't live without ..钙调磷酸酶抑制剂:40 年后,不可或缺的药物..
J Immunol. 2013 Dec 15;191(12):5785-91. doi: 10.4049/jimmunol.1390055.
6
Angiotensin II contributes to podocyte injury by increasing TRPC6 expression via an NFAT-mediated positive feedback signaling pathway.血管紧张素 II 通过 NFAT 介导的正反馈信号通路增加 TRPC6 表达,从而导致足细胞损伤。
Am J Pathol. 2011 Oct;179(4):1719-32. doi: 10.1016/j.ajpath.2011.06.033. Epub 2011 Aug 11.
7
Neurexin-1, a presynaptic adhesion molecule, localizes at the slit diaphragm of the glomerular podocytes in kidneys.神经连接蛋白-1 是一种突触前黏附分子,定位于肾脏肾小球足细胞的裂孔隔膜。
Am J Physiol Regul Integr Comp Physiol. 2011 Feb;300(2):R340-8. doi: 10.1152/ajpregu.00640.2009. Epub 2010 Nov 3.
8
Activation of NFAT signaling in podocytes causes glomerulosclerosis.NFAT 信号通路在足细胞中的激活导致肾小球硬化。
J Am Soc Nephrol. 2010 Oct;21(10):1657-66. doi: 10.1681/ASN.2009121253. Epub 2010 Jul 22.
9
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.肾足细胞的肌动蛋白细胞骨架是环孢素A抗蛋白尿作用的直接靶点。
Nat Med. 2008 Sep;14(9):931-8. doi: 10.1038/nm.1857.
10
Dissociation of NEPH1 from nephrin is involved in development of a rat model of focal segmental glomerulosclerosis.NEPH1 与nephrin 的解离参与局灶节段性肾小球硬化大鼠模型的发展。
Am J Physiol Renal Physiol. 2008 Nov;295(5):F1376-87. doi: 10.1152/ajprenal.00075.2008. Epub 2008 Aug 20.